CD4 and Alzheimer disease: Interestingly, CD4+ memory Th2 cells are most abundant in inflamed lessions [14] and blocking the antigen presents to CD4+ memory T-cells by a humanized monoclonal antibody has demonstrated to be effective in the treatment of AD [39].